nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—Dermatitis atopic—Tretinoin—peripheral nervous system neoplasm	0.026	0.026	CcSEcCtD
Propantheline—Dermatitis atopic—Isotretinoin—peripheral nervous system neoplasm	0.026	0.026	CcSEcCtD
Propantheline—Dermatitis atopic—Melphalan—peripheral nervous system neoplasm	0.0256	0.0256	CcSEcCtD
Propantheline—Dermatitis atopic—Alitretinoin—peripheral nervous system neoplasm	0.0197	0.0197	CcSEcCtD
Propantheline—Abdominal distension—Isotretinoin—peripheral nervous system neoplasm	0.0121	0.0121	CcSEcCtD
Propantheline—Abdominal distension—Tretinoin—peripheral nervous system neoplasm	0.0121	0.0121	CcSEcCtD
Propantheline—Dysphagia—Tretinoin—peripheral nervous system neoplasm	0.0121	0.0121	CcSEcCtD
Propantheline—Dysphagia—Isotretinoin—peripheral nervous system neoplasm	0.0121	0.0121	CcSEcCtD
Propantheline—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.0107	0.0107	CcSEcCtD
Propantheline—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.0107	0.0107	CcSEcCtD
Propantheline—Dysphagia—Dactinomycin—peripheral nervous system neoplasm	0.00985	0.00985	CcSEcCtD
Propantheline—Abdominal distension—Alitretinoin—peripheral nervous system neoplasm	0.0092	0.0092	CcSEcCtD
Propantheline—Dysphagia—Alitretinoin—peripheral nervous system neoplasm	0.00914	0.00914	CcSEcCtD
Propantheline—Flushing—Tretinoin—peripheral nervous system neoplasm	0.00896	0.00896	CcSEcCtD
Propantheline—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.00896	0.00896	CcSEcCtD
Propantheline—Flushing—Melphalan—peripheral nervous system neoplasm	0.00884	0.00884	CcSEcCtD
Propantheline—Dermatitis atopic—Epirubicin—peripheral nervous system neoplasm	0.00861	0.00861	CcSEcCtD
Propantheline—Tension—Tretinoin—peripheral nervous system neoplasm	0.00824	0.00824	CcSEcCtD
Propantheline—Tension—Isotretinoin—peripheral nervous system neoplasm	0.00824	0.00824	CcSEcCtD
Propantheline—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.00816	0.00816	CcSEcCtD
Propantheline—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.00816	0.00816	CcSEcCtD
Propantheline—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00815	0.00815	CcSEcCtD
Propantheline—Erectile dysfunction—Vincristine—peripheral nervous system neoplasm	0.00811	0.00811	CcSEcCtD
Propantheline—Dermatitis atopic—Doxorubicin—peripheral nervous system neoplasm	0.00797	0.00797	CcSEcCtD
Propantheline—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00792	0.00792	CcSEcCtD
Propantheline—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00792	0.00792	CcSEcCtD
Propantheline—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.00742	0.00742	CcSEcCtD
Propantheline—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.00742	0.00742	CcSEcCtD
Propantheline—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.00732	0.00732	CcSEcCtD
Propantheline—Dysphagia—Etoposide—peripheral nervous system neoplasm	0.00713	0.00713	CcSEcCtD
Propantheline—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.00699	0.00699	CcSEcCtD
Propantheline—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.00699	0.00699	CcSEcCtD
Propantheline—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00691	0.00691	CcSEcCtD
Propantheline—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00691	0.00691	CcSEcCtD
Propantheline—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00691	0.00691	CcSEcCtD
Propantheline—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00686	0.00686	CcSEcCtD
Propantheline—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00686	0.00686	CcSEcCtD
Propantheline—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.00679	0.00679	CcSEcCtD
Propantheline—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00677	0.00677	CcSEcCtD
Propantheline—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00669	0.00669	CcSEcCtD
Propantheline—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00669	0.00669	CcSEcCtD
Propantheline—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.0066	0.0066	CcSEcCtD
Propantheline—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00625	0.00625	CcSEcCtD
Propantheline—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.0062	0.0062	CcSEcCtD
Propantheline—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.0062	0.0062	CcSEcCtD
Propantheline—Salivary hypersecretion—Epirubicin—peripheral nervous system neoplasm	0.00619	0.00619	CcSEcCtD
Propantheline—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00618	0.00618	CcSEcCtD
Propantheline—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00609	0.00609	CcSEcCtD
Propantheline—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00609	0.00609	CcSEcCtD
Propantheline—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.006	0.006	CcSEcCtD
Propantheline—Constipation—Topotecan—peripheral nervous system neoplasm	0.00591	0.00591	CcSEcCtD
Propantheline—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00586	0.00586	CcSEcCtD
Propantheline—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00586	0.00586	CcSEcCtD
Propantheline—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00578	0.00578	CcSEcCtD
Propantheline—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.00573	0.00573	CcSEcCtD
Propantheline—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00569	0.00569	CcSEcCtD
Propantheline—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00565	0.00565	CcSEcCtD
Propantheline—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00565	0.00565	CcSEcCtD
Propantheline—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00563	0.00563	CcSEcCtD
Propantheline—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00549	0.00549	CcSEcCtD
Propantheline—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00545	0.00545	CcSEcCtD
Propantheline—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00545	0.00545	CcSEcCtD
Propantheline—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00538	0.00538	CcSEcCtD
Propantheline—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.0053	0.0053	CcSEcCtD
Propantheline—Flushing—Etoposide—peripheral nervous system neoplasm	0.0053	0.0053	CcSEcCtD
Propantheline—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00524	0.00524	CcSEcCtD
Propantheline—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.0052	0.0052	CcSEcCtD
Propantheline—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00511	0.00511	CcSEcCtD
Propantheline—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00509	0.00509	CcSEcCtD
Propantheline—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00507	0.00507	CcSEcCtD
Propantheline—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00505	0.00505	CcSEcCtD
Propantheline—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00505	0.00505	CcSEcCtD
Propantheline—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00501	0.00501	CcSEcCtD
Propantheline—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00499	0.00499	CcSEcCtD
Propantheline—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00496	0.00496	CcSEcCtD
Propantheline—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00492	0.00492	CcSEcCtD
Propantheline—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00492	0.00492	CcSEcCtD
Propantheline—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00485	0.00485	CcSEcCtD
Propantheline—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.0047	0.0047	CcSEcCtD
Propantheline—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00462	0.00462	CcSEcCtD
Propantheline—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00462	0.00462	CcSEcCtD
Propantheline—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00457	0.00457	CcSEcCtD
Propantheline—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00453	0.00453	CcSEcCtD
Propantheline—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00453	0.00453	CcSEcCtD
Propantheline—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00453	0.00453	CcSEcCtD
Propantheline—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00444	0.00444	CcSEcCtD
Propantheline—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00443	0.00443	CcSEcCtD
Propantheline—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00439	0.00439	CcSEcCtD
Propantheline—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00436	0.00436	CcSEcCtD
Propantheline—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00436	0.00436	CcSEcCtD
Propantheline—Rash—Topotecan—peripheral nervous system neoplasm	0.00436	0.00436	CcSEcCtD
Propantheline—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00435	0.00435	CcSEcCtD
Propantheline—Headache—Topotecan—peripheral nervous system neoplasm	0.00433	0.00433	CcSEcCtD
Propantheline—Rash—Tretinoin—peripheral nervous system neoplasm	0.00432	0.00432	CcSEcCtD
Propantheline—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00432	0.00432	CcSEcCtD
Propantheline—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00432	0.00432	CcSEcCtD
Propantheline—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00432	0.00432	CcSEcCtD
Propantheline—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00432	0.00432	CcSEcCtD
Propantheline—Vomiting—Melphalan—peripheral nervous system neoplasm	0.0043	0.0043	CcSEcCtD
Propantheline—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00429	0.00429	CcSEcCtD
Propantheline—Headache—Tretinoin—peripheral nervous system neoplasm	0.00429	0.00429	CcSEcCtD
Propantheline—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00428	0.00428	CcSEcCtD
Propantheline—Constipation—Vincristine—peripheral nervous system neoplasm	0.00428	0.00428	CcSEcCtD
Propantheline—Rash—Melphalan—peripheral nervous system neoplasm	0.00427	0.00427	CcSEcCtD
Propantheline—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00426	0.00426	CcSEcCtD
Propantheline—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00413	0.00413	CcSEcCtD
Propantheline—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00413	0.00413	CcSEcCtD
Propantheline—Nausea—Topotecan—peripheral nervous system neoplasm	0.0041	0.0041	CcSEcCtD
Propantheline—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00409	0.00409	CcSEcCtD
Propantheline—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00407	0.00407	CcSEcCtD
Propantheline—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00407	0.00407	CcSEcCtD
Propantheline—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00406	0.00406	CcSEcCtD
Propantheline—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.00402	0.00402	CcSEcCtD
Propantheline—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00402	0.00402	CcSEcCtD
Propantheline—Nausea—Melphalan—peripheral nervous system neoplasm	0.00402	0.00402	CcSEcCtD
Propantheline—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.004	0.004	CcSEcCtD
Propantheline—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00396	0.00396	CcSEcCtD
Propantheline—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00383	0.00383	CcSEcCtD
Propantheline—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00373	0.00373	CcSEcCtD
Propantheline—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.00372	0.00372	CcSEcCtD
Propantheline—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.0037	0.0037	CcSEcCtD
Propantheline—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00369	0.00369	CcSEcCtD
Propantheline—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00365	0.00365	CcSEcCtD
Propantheline—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00361	0.00361	CcSEcCtD
Propantheline—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00359	0.00359	CcSEcCtD
Propantheline—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00356	0.00356	CcSEcCtD
Propantheline—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00356	0.00356	CcSEcCtD
Propantheline—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00353	0.00353	CcSEcCtD
Propantheline—Constipation—Etoposide—peripheral nervous system neoplasm	0.00347	0.00347	CcSEcCtD
Propantheline—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00344	0.00344	CcSEcCtD
Propantheline—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00334	0.00334	CcSEcCtD
Propantheline—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00333	0.00333	CcSEcCtD
Propantheline—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00331	0.00331	CcSEcCtD
Propantheline—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.0033	0.0033	CcSEcCtD
Propantheline—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.0033	0.0033	CcSEcCtD
Propantheline—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00328	0.00328	CcSEcCtD
Propantheline—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Propantheline—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00326	0.00326	CcSEcCtD
Propantheline—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00325	0.00325	CcSEcCtD
Propantheline—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00322	0.00322	CcSEcCtD
Propantheline—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Propantheline—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00318	0.00318	CcSEcCtD
Propantheline—Rash—Vincristine—peripheral nervous system neoplasm	0.00316	0.00316	CcSEcCtD
Propantheline—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00315	0.00315	CcSEcCtD
Propantheline—Headache—Vincristine—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Propantheline—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00309	0.00309	CcSEcCtD
Propantheline—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00299	0.00299	CcSEcCtD
Propantheline—Nausea—Vincristine—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Propantheline—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Propantheline—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00291	0.00291	CcSEcCtD
Propantheline—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00281	0.00281	CcSEcCtD
Propantheline—Rash—Cisplatin—peripheral nervous system neoplasm	0.00279	0.00279	CcSEcCtD
Propantheline—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00279	0.00279	CcSEcCtD
Propantheline—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Propantheline—Tension—Epirubicin—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Propantheline—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00271	0.00271	CcSEcCtD
Propantheline—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00268	0.00268	CcSEcCtD
Propantheline—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00263	0.00263	CcSEcCtD
Propantheline—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00263	0.00263	CcSEcCtD
Propantheline—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00258	0.00258	CcSEcCtD
Propantheline—Rash—Etoposide—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Propantheline—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00255	0.00255	CcSEcCtD
Propantheline—Headache—Etoposide—peripheral nervous system neoplasm	0.00254	0.00254	CcSEcCtD
Propantheline—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Propantheline—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Propantheline—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Propantheline—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Propantheline—Nausea—Etoposide—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Propantheline—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Propantheline—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Propantheline—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Propantheline—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00227	0.00227	CcSEcCtD
Propantheline—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00222	0.00222	CcSEcCtD
Propantheline—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Propantheline—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Propantheline—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Propantheline—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Propantheline—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Propantheline—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Propantheline—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00194	0.00194	CcSEcCtD
Propantheline—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Propantheline—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Propantheline—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Propantheline—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Propantheline—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Propantheline—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Propantheline—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Propantheline—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Propantheline—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Propantheline—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Propantheline—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Propantheline—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Propantheline—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Propantheline—Rash—Epirubicin—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Propantheline—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Propantheline—Headache—Epirubicin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Propantheline—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Propantheline—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Propantheline—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Propantheline—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Propantheline—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Propantheline—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Propantheline—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
